Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
Abstract Aim This systematic review and random‐effect model, network meta‐analysis of the phase 3 trials in Japan assessed the efficacy and safety profile of lurasidone compared with olanzapine and quetiapine extended‐release (QUE‐XR) for the treatment of bipolar depression. Methods The study includ...
Main Authors: | Taro Kishi, Reiji Yoshimura, Kenji Sakuma, Makoto Okuya, Nakao Iwata |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12137 |
Similar Items
-
Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
by: Taro Kishi, et al.
Published: (2019-09-01) -
Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study
by: Xiangyuan Diao, et al.
Published: (2022-11-01) -
A diagnostic test to examine early improvement as a predictor of later response to lurasidone in bipolar depression
by: Taro Kishi, et al.
Published: (2023-03-01) -
Electrochemical Studies for the Determination of Quetiapine Fumarate and Olanzapine Antipsychotic Drugs
by: Manal A. El-Shal
Published: (2013-08-01) -
Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01)